Where to buy NAD+ is a question with five answers, and they are not variations of one another. A drip bar, a compounding pharmacy, a research supplier, an overseas factory and a supplement shelf are five different businesses selling five different things under one name.
Key takeaways
- Unlike the peptides covered on this site, NAD+ has a genuine clinic channel and a genuine pharmacy channel. NAD is on FDA's 503A Category 1 list, which is a non-enforcement position during an open evaluation rather than an approval.
- The clinic channel is exactly where FDA found the problem. Its compounding notice describes compounders using food-grade NAD+ sold by repackagers to make intravenous products.
- The supplement aisle is not this purchase. Precursors sold as capsules are different substances with their own separate history, and buying one is not buying NAD+.
- Overseas bulk pricing only looks good at quantities built for factories, and it is the same trade that put food-grade material into the compounding chain.
- Whichever channel you use, one question travels with you: does the batch report cover bacterial endotoxins, or only identity and purity.
The vendor we point lifters to
NAD+ from Ascension Peptides
Independently assayed material, dispatched from the US. The vial drops by half with the code below.
Quoted per 100 mg because NAD+ is dosed in hundreds of milligrams, not the single milligrams a peptide vial holds. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price. Free shipping starts at $250.
- Two independent lab reports per batch
- Free delivery above $250
- Same-day dispatch on orders before 2pm CST
Research material, laboratory use only, not for human consumption. Affiliate links: we may earn a commission at no extra cost to you. Pricing verified August 20, 2026.
Where to buy NAD+: the five channels side by side
| Channel | Can it supply NAD+ | What you actually hold | How the price is set | Main exposure |
|---|---|---|---|---|
| Research supplier | Yes | A labeled gram with a batch certificate | Per vial, published, comparable | Supplier quality varies enormously |
| IV clinic or drip bar | Yes, as a service | An infusion administered on site | Per session, material cost invisible | Grade of the underlying bulk, which you cannot see |
| Compounding pharmacy | Yes, with a prescription | A compounded preparation for one named patient | Per prescription, plus the visit that generated it | Compounded is not approved, and the policy behind it is provisional |
| Overseas bulk seller | Yes | Powder in quantities meant for a factory | Per kilogram, with minimums | Food-grade material, transit, no recourse |
| Supplement shelf | No | Capsules of a precursor, which is a different substance | Per bottle | Buying the wrong thing entirely |
The row that surprises people is the third one. On this site, the compounding answer is usually a flat no, because there is nothing approved to compound from. NAD+ is the exception, and the reason is regulatory rather than scientific.
Why NAD+ has channels that peptides do not
BPC-157, MOTS-c and retatrutide all fail the compounding test for the same reason: no approved product, no listed bulk substance, no prescription to write. We said so plainly in MOTS-c without prescription and retatrutide without prescription.
NAD is in a different position. It appears in FDA's 503A Category 1 list, "Bulk Drug Substances Under Evaluation," in the category lists updated May 14, 2026. Category 1 means the agency does not intend to take action against a compounder for compounding with that substance provided the conditions in its guidance are met. That is a non-enforcement position while an evaluation runs, and it is not an approval, not a guarantee of quality, and not permanent.
That single listing is what makes the clinic and pharmacy channels function. It is also why competing pages get this wrong in both directions: some describe compounded NAD+ as if it were an approved medicine, and some claim it is banned from compounding outright. Neither is what the list says. The careful version is in NAD+ without prescription.
Research suppliers: the channel with the paperwork
This is the channel that sells material rather than a service, and the one where you can inspect what you are buying before you pay. Listings state a quantity, a lot, and a testing position, and the good ones publish the certificate on the page.
It is also the channel where quality spreads widest, because anyone can build a storefront. The distinguishing features are boring: a batch-specific certificate rather than a catalog one, a named third-party laboratory, mass spectrometry alongside a purity chromatogram, domestic dispatch, and an explicit research-use position with no human-use claims. The full checklist is in NAD+ where to buy.
The listing we track sits here. Ascension's NAD+ 1,000 mg page lists at $104.00, falls to $52.00 with the code, and publishes two independent third-party reports for the batch, currently Kovera Labs 25-05260628 and MZ Biolabs 25-01260229, with same-day dispatch before 2pm CST. What you should still ask, here and everywhere, is whether those reports carry a bacterial endotoxins result.
Clinics and drip bars: a service, with the material out of sight
Wellness clinics, med spas and mobile infusion services sell NAD+ openly, usually as a drip lasting a couple of hours, sometimes as an intramuscular shot, and often as a package of sessions. The price is set as a service. You are paying for the room, the nurse, the time and the markup, and the cost of the underlying material is not a line item you get to see.
That invisibility is the whole risk, and it is not hypothetical. FDA's notice reminding compounders to use ingredients suitable for sterile compounding, content current as of 10/30/2024, states the agency "is aware of compounders using food-grade nicotinamide adenine dinucleotide (NAD+) sold by repackagers to make intravenous products," and that food-grade ingredients "are not suitable for compounding sterile drugs without appropriate processing, due to the high risk of contamination with microbes and endotoxins."
The same notice records adverse event reports "following use of NAD+ injectable drugs, including severe chills, shaking, vomiting and fatigue with some requiring medical treatment," reactions FDA called "consistent with excessive levels of endotoxins."
So the honest read of this channel is that paying more does not buy you a better ingredient, because nothing about a comfortable waiting room tells you what grade the bulk was. What you can do is ask, in these words: who compounds this, is the substance pharmaceutical grade, and does the certificate include endotoxin testing. A clinic that can answer has probably had to answer before. The local-search version of this sits in NAD+ near me, and the session arithmetic in NAD+ price.
Compounding pharmacies: real, conditional, and not a shortcut
A 503A pharmacy compounds for an individual patient against a prescription, so this route starts with a prescriber, not with a checkout. Some telehealth services will run that consultation and route to a partnered pharmacy, which is why "prescription NAD+" ads exist at all.
Three things are worth holding onto. Compounded preparations are not FDA approved, and the agency's compounding questions and answers is direct about that. The policy behind the ingredient is provisional, which is what Category 1 means. And a prescription does not by itself certify the bulk substance, which is precisely why the food-grade notice was addressed to compounders in the first place.
Registered outsourcing facilities operating under 503B are a separate tier with different obligations, and FDA publishes a current list you can search if a clinic names its supplier.
Overseas bulk: cheap per kilogram, expensive per mistake
Marketplace listings from overseas manufacturers quote NAD+ per kilogram, sometimes at prices that make the domestic figure look absurd. The minimums are the tell. Pricing turns attractive at quantities built for a factory, not for a person, and a buyer who follows that route to save money ends up with a large stock of one unverified lot.
This is also, structurally, where the repackager problem starts. Food-grade material moving through a trading chain, relabeled along the way, is the exact pathway FDA described. Add weeks in transit, a certificate that may belong to a different lot, and a dispute process that resolves to nothing, and the saving disappears the first time an order goes wrong. Customs is its own risk: FDA's personal importation page sets out how limited the exceptions are.
The supplement aisle is a different purchase
Search results mix in capsules of NAD+ precursors, and it is worth being precise here rather than dismissive. Those precursors are different substances with their own separate regulatory history, which this article does not attempt to summarise. What matters for a buying decision is simpler: a capsule of a precursor is not the substance in a research vial or a clinic drip, the routes are different, and the two questions cannot be answered with the same product.
Oral NAD+ itself, sold as a powder or a capsule, is again not the same purchase as sterile material intended for injection, and none of the grade and endotoxin logic above transfers across.
What this means for a training block
For a lifter, the channel decision is really a decision about what you can verify. A clinic gives you supervision and no visibility into the material. A research supplier gives you documentation and no supervision. A pharmacy gives you a prescriber and a preparation made under a provisional policy. Nobody in any channel is offering evidence that this improves how you train, because the registered trial record does not contain it.
If flat sessions are the reason you are reading this, the boring explanations deserve a pass first: sleep debt, an aggressive deficit, or lean-mass drift on an incretin drug, covered in sleep and myostatin and myostatin inhibitors and GLP-1 muscle loss. If you have exhausted those and still want to run it, the research-supplier route is the one where the questions in this article can actually be asked and answered. For dosing, which no supplier is allowed to discuss, PeptideDosage keeps a NAD+ dosage reference.
Frequently asked questions
Where can I buy NAD+ without going to a clinic?
From a research supplier that sells it as laboratory material with a batch certificate. That is the only channel that hands you the container and the paperwork rather than a service, and it is the one where grade and endotoxin questions can be put to a named seller before you pay.
Can a compounding pharmacy make NAD+?
Yes, with a prescription, which is unusual for compounds covered on this site. NAD sits in FDA's 503A Category 1, meaning it is under evaluation and the agency has said it does not intend to act against compounders using it while its guidance conditions are met. Compounded preparations are still not FDA approved.
Is a drip bar safer than buying a vial?
Not automatically. FDA's notice describes compounders using food-grade NAD+ sold by repackagers for intravenous products and ties reported reactions of severe chills, shaking, vomiting and fatigue to excessive endotoxin levels. Supervision helps if something goes wrong, but it does not tell you what grade the bulk was.
Are NAD+ capsules on a supplement shelf the same thing?
No. Most shelf products are precursors, which are separate substances with their own history, and even an oral NAD+ powder is not the sterile material a clinic or a research listing is talking about. Treat it as a different purchase, not a cheaper version of the same one.
Why is overseas bulk NAD+ so much cheaper per gram?
Because it is priced for industrial quantities with minimums to match, and often at a grade intended for food or supplement use rather than sterile preparation. That is the same trade FDA described flowing through repackagers into compounded intravenous products.
This article is for educational purposes only and is not medical advice. NAD+ is a coenzyme rather than an approved injectable medicine: there is no FDA-approved NAD+ drug product, material sold by research suppliers is labeled for laboratory use only and not for human consumption, and compounded preparations exist under a stated enforcement policy rather than an approval. Speak with a qualified healthcare professional before making any decision involving injections, infusions or off-label compounds.